Varex Imaging (NASDAQ:VREX) Issues Q2 2026 Earnings Guidance

Varex Imaging (NASDAQ:VREX) updated its second quarter 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.150-0.250 for the period, compared to the consensus estimate of 0.190. The company issued revenue guidance of $210.0 million-$215.0 million, compared to the consensus revenue estimate of $214.4 million.

Varex Imaging Trading Up 0.8%

Shares of NASDAQ:VREX traded up $0.11 during trading on Tuesday, reaching $14.15. 513,097 shares of the stock were exchanged, compared to its average volume of 337,193. Varex Imaging has a 12-month low of $6.76 and a 12-month high of $14.56. The firm’s 50-day moving average price is $12.84 and its 200 day moving average price is $11.74. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.83 and a current ratio of 3.43. The firm has a market cap of $593.17 million, a price-to-earnings ratio of -8.32 and a beta of 0.90.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. The company had revenue of $209.60 million for the quarter, compared to analyst estimates of $207.83 million. Varex Imaging had a negative net margin of 8.32% and a positive return on equity of 7.19%. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. On average, sell-side analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on VREX shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a research report on Monday, December 29th. B. Riley Financial reiterated a “buy” rating and set a $16.00 price objective on shares of Varex Imaging in a research report on Wednesday, November 19th. Oppenheimer cut their price target on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Jefferies Financial Group reaffirmed a “hold” rating and set a $14.50 target price on shares of Varex Imaging in a research note on Monday, February 2nd. Finally, Wall Street Zen upgraded shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 22nd. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $16.17.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in VREX. Vanguard Group Inc. increased its position in shares of Varex Imaging by 4.4% in the third quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock valued at $37,074,000 after acquiring an additional 126,396 shares during the last quarter. Millennium Management LLC raised its position in shares of Varex Imaging by 119.8% in the 3rd quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock valued at $11,323,000 after buying an additional 497,650 shares in the last quarter. Jacobs Levy Equity Management Inc. raised its stake in Varex Imaging by 5.3% during the third quarter. Jacobs Levy Equity Management Inc. now owns 529,793 shares of the company’s stock worth $6,569,000 after acquiring an additional 26,488 shares in the last quarter. AQR Capital Management LLC grew its position in Varex Imaging by 50.3% during the 2nd quarter. AQR Capital Management LLC now owns 471,623 shares of the company’s stock worth $4,089,000 after acquiring an additional 157,869 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its stake in shares of Varex Imaging by 26.0% in the third quarter. Bridgeway Capital Management LLC now owns 399,276 shares of the company’s stock worth $4,951,000 after purchasing an additional 82,426 shares during the last quarter.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.